RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ampio Pharmaceuticals Stock

Ampio Pharmaceuticals Stocks 2024

Ampio Pharmaceuticals Stocks

810,110

Ticker

AMPE

ISIN

US03209T1097

WKN

A1JGFU

In 2024, Ampio Pharmaceuticals had 810,110 outstanding stocks, a 0% change from the 810,110 stocks in the previous year.

The Ampio Pharmaceuticals Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2026e810.11
2025e810.11
2024e810.11
2023810.11
2022750
2021660
2020580
2019440
2018240
2017220
2016180
2015170
2014170
2013130
2012110
201190
201050
200950
2008-
2007-
2006-

Ampio Pharmaceuticals shares outstanding

The number of shares was Ampio Pharmaceuticals in 2023 — This indicates how many shares 810,110 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Ampio Pharmaceuticals earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Ampio Pharmaceuticals's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Ampio Pharmaceuticals’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ampio Pharmaceuticals's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Ampio Pharmaceuticals Aktienanalyse

What does Ampio Pharmaceuticals do?

Ampio Pharmaceuticals Inc is a biopharmaceutical company specialized in developing and marketing novel therapies for various diseases. The company was founded in 2010 and is headquartered in Englewood, Colorado. The history of Ampio Pharmaceuticals began with a goal: to realize the vision of developing innovative therapies that benefit patients. The founding idea focused on the development of a new therapy for osteoarthritis. Over time, however, the company diversified and specialized in the development of drugs for other areas such as diabetes, eye diseases, and pneumonia. Ampio Pharmaceuticals' business model is focused on cutting-edge technologies and scientific knowledge. The company employs an integrative approach that utilizes a variety of techniques, including cell-based therapies, gene therapies, and drug development. The company's core competencies lie in research, development, and marketing of innovative therapy options. Ampio Pharmaceuticals is divided into various business units. For example, the company is engaged in the development of drugs based on AMPio technologies. These compounds form the core of the therapy approaches and have already shown promising results in clinical trials. The company also emphasizes collaboration with partners to expedite the development of new therapy options. Another focus of Ampio Pharmaceuticals is the development of therapies for osteoarthritis. The company has developed a range of therapeutics targeting various aspects of the disease, such as anti-inflammatory agents and substances for joint cartilage regeneration. These therapies aim to alleviate the symptoms of osteoarthritis and provide patients with a higher quality of life. In addition to developing new therapy options, Ampio Pharmaceuticals also conducts clinical trials. These studies are designed to test the efficacy and safety of the developed drugs. Ampio Pharmaceuticals is committed to providing the highest standard of medical care by substantiating the safety and efficacy of their drugs through clinical trials. As a company specialized in drug development, Ampio Pharmaceuticals has launched a number of products on the market. These include Ampion, an injectable therapy for knee osteoarthritis, and Optina, an orally administered drug for the treatment of diabetes-related retinopathy. Overall, Ampio Pharmaceuticals is an innovative company specializing in the development of new therapy options. The company leverages modern technologies and scientific knowledge and aims to improve patients' lives through highly effective therapies. Ampio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Ampio Pharmaceuticals's Shares Outstanding

Ampio Pharmaceuticals's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Ampio Pharmaceuticals’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Ampio Pharmaceuticals’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Ampio Pharmaceuticals’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Ampio Pharmaceuticals stock

How many stocks are there of Ampio Pharmaceuticals?

The current number of stocks of Ampio Pharmaceuticals is 810,110 undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Ampio Pharmaceuticals are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Ampio Pharmaceuticals evolved in recent years?

The number of shares of Ampio Pharmaceuticals has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Ampio Pharmaceuticals as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Ampio Pharmaceuticals?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Ampio Pharmaceuticals pay?

Over the past 12 months, Ampio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ampio Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Ampio Pharmaceuticals?

The current dividend yield of Ampio Pharmaceuticals is .

When does Ampio Pharmaceuticals pay dividends?

Ampio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ampio Pharmaceuticals?

Ampio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Ampio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ampio Pharmaceuticals located?

Ampio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ampio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ampio Pharmaceuticals from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Ampio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Ampio Pharmaceuticals in the year 2023?

In the year 2023, Ampio Pharmaceuticals distributed 0 USD as dividends.

In which currency does Ampio Pharmaceuticals pay out the dividend?

The dividends of Ampio Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ampio Pharmaceuticals

Our stock analysis for Ampio Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ampio Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.